Latest International Expansion News

Page 2 of 56
Eden Innovations has secured a fifth EdenCrete Pz7 order from Holcim Ecuador, taking cumulative purchases from the customer beyond US$1 million. The repeat demand is prompting Eden to assess whether South America deserves a larger strategic focus.
Victor Sage
Victor Sage
29 Oct 2026
Amotiv has cut its FY27 revenue and underlying EBITA outlook by up to 5% after first-quarter revenue fell 5% on weaker vehicle demand and Thailand flooding. The ASX-listed automotive parts group will nevertheless launch another buyback of up to 5% of its shares, betting its depressed valuation will recover.
Victor Sage
Victor Sage
27 Oct 2026
Biome Australia has reported record pharmacy sell-through, further market-share gains and positive operating cash flow as it begins manufacturing Activated Probiotics domestically. The quarter also moved its China expansion and BMB18 clinical trial closer to key execution milestones.
Ada Torres
Ada Torres
26 Oct 2026
Objective Corporation delivered 9% revenue growth and a 5% lift in net profit for FY2026, but the loss of a long-running Defence agreement and a separate NHVR contract will pressure recurring revenue in the year ahead. Management expects adjusted EBITDA of at least $40 million in FY2027 as it keeps investing in AI, sales capacity and potential acquisitions.
Victor Sage
Victor Sage
23 Oct 2026
Magellan Financial Group says its Barrenjoey merger is integrating ahead of schedule, with annual synergies now forecast at $15 million. The group also reported $778 million of pro forma FY26 revenue, while warning that early FY27 trading has been softer in Financial Markets and Investment Management.
Claire Turing
Claire Turing
22 Oct 2026
Airtasker delivered its strongest GMV growth in four years in FY26, but the expansion still consumed cash as international investment accelerated. The ASX-listed marketplace is now targeting positive free cash flow in FY27 while scaling membership and reducing UK investment.
Sophie Babbage
Sophie Babbage
21 Oct 2026
BLS Pharmaceuticals has started FY27 with its strongest quarter on record, reporting A$26.7 million in unaudited revenue and positive operating cash flow. The company reaffirmed its A$105 million to A$115 million revenue guidance while continuing to invest in Australian and Scottish manufacturing capacity.
Victor Sage
Victor Sage
21 Oct 2026
Sigma Healthcare has entered FY27 with double-digit Chemist Warehouse sales growth, stronger earnings and a merger integration program targeting $100 million in annual synergies by FY29. The next test is whether store expansion and technology consolidation can convert momentum into durable cash returns.
Ada Torres
Ada Torres
21 Oct 2026
Rua Bioscience has raised approximately NZ$1.0 million through its rights offer, well short of the NZ$2.8 million sought. The medicinal cannabis company says it still needs more working capital to fund inventory for its UK expansion.
Ada Torres
Ada Torres
20 Oct 2026
ECS Botanics has delivered a fifth consecutive quarter of positive operating cash flow, while branded sales and international expansion continue to reshape the business. The next test is whether planned UK and Polish launches can convert into recurring revenue.
Ada Torres
Ada Torres
19 Oct 2026
Australian Vintage has returned to positive operating cash flow, but its FY26 statutory loss widened sharply after a $27 million inventory write-down and deferred tax charge. The wine group is betting that Poco Vino growth, further restructuring and lower stock levels can convert the cash improvement into debt reduction in FY27.
Victor Sage
Victor Sage
16 Oct 2026
Dusk Group has carried its FY26 momentum into the new financial year, with like-for-like sales up 7.2% in the first 15 weeks despite operating six fewer stores. The home-fragrance retailer is now preparing a tightly controlled South African launch while an unresolved ACCC court case remains a material complication.
Logan Eniac
Logan Eniac
16 Oct 2026

Browse the archive

Full archive